Skip to main content
. Author manuscript; available in PMC: 2014 Nov 21.
Published in final edited form as: Nanoscale. 2013 Oct 2;5(22):10719–10728. doi: 10.1039/c3nr03595f

Table 2.

Advantages and disadvantages of various species in bleeding hemorrhagic trauma models.

Species Advantages Disadvantages Refs.
Mouse Economy, wide availability of genetically-mutated strains, and the associated host of immune/biochemical assays High platelet count, limited correlation to human physiology, and an insensitivity to many coagulation defects, small size makes some interventions technically challenging 4247
Rat Similar to mouse, surgical procedures are technically easier to perform on the rat, and they are still as widely available and relatively cheap like mice. The coagulation cascade and associated mechanism appear to be relatively well-conserved: including platelet physiology, hepatic blood flow, and blood pressure regulation High platelet count and a relatively lower clotting time compared to humans, small size still presents some technical challenges 2224,4560
Rabbit Platelet counts, physiology and in vitro clotting parameters are extremely well-correlated to humans, making them a viable candidate for an in vivo model of hemorrhage, and experimental therapies. More expensive and fewer on-shelf bio-assays than rats or mice, insensitive to thrombin receptor peptides that activate human platelets. 12,4547,5961
Pig The cardiovascular system is well-correlated with human parameters and the comparable size allows for devices to be used in both clinical and research environment without modification. Wound-healing process appears to be similar to the human due to similarities between porcine and human skin. Expensive, need technically-trained staff, sensitivity to complement activation related pseudoallergy (CARPA). 41,4547,6265
Primate Best animal analog of humans available. Controversial, very expensive, highly regulated. These studies are generally performed prior to initiating a clinical trial to test for safety/efficacy. 13,46,47